Image

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market – Industry Trends and Forecast to 2030

Healthcare

Image

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Published Report
  • Mar 2023
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 70

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 867.09 USD Thousand
Diagram Market Size (Forecast Year) USD 1,260.66 USD Thousand
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Saudi Arabia, Turkey, and Egypt In Vitro Diagnostics (IVD) Quality Control Market, By Product and Services (Quality Control Products and Quality Control Services), Application (Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Coagulation/Hemostasis, Microbiology, and Others), Sector (Clinical and Non-Clinical), End User (Clinical Laboratories, Academic and Research Institutes, Blood Banks, Biotechnology Industry, Pharmaceutical Industry, and Others)-Industry Trends and Forecast to 2030.

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market Analysis and Size

The rising prevalence of chronic diseases across Saudi Arabia, Turkey, and Egypt has enhanced the market demand. The rising healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various product launches and approvals during this crucial period. In addition, the increase in improved quality control services also contributes to the rising demand for the IVD quality control market.

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control MarketSaudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market

Saudi Arabia, Turkey, and Egypt In vitro diagnostics (IVD) quality control market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.8% in the forecast period of 2023 to 2030 and is expected to reach USD 1,260.66 thousand by 2030 from USD 867.09 thousand in 2022.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Thousand

Segments Covered

Product and Services (Quality Control Products and Quality Control Services), Application (Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Coagulation/Hemostasis, Microbiology, and Others), Sector (Clinical and Non-Clinical), End User (Clinical Laboratories, Academic and Research Institutes, Blood Banks, Biotechnology Industry, Pharmaceutical Industry, and Others)

Countries Covered

Saudi Arabia, Turkey, and Egypt

Market Players Covered

The major companies which are dealing in the market are Bio-Rad Laboratories, Inc, Siemens Healthcare Private Limited, Sysmex Europe SE, Randox Laboratories Ltd., Sera Care, Thermo Fisher Scientific Inc., Beckman Coulter, Inc., Technopath Clinical Diagnostics, DiaSorin S.p.A., Agappe Diagnostics Ltd, and Spectrum Diagnostics. among others

Market Definition

In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.

IVD quality controls are samples/materials used to validate the reliability of the IVD testing system to ensure the accuracy of test results and evaluate the impact of factors such as environmental conditions and operator’s performance on test results. Moreover, they can also be used to monitor a patient’s health, cure diseases, and also enable medical professionals to identify the most effective treatment procedure or therapy for the patient.

 In Vitro Diagnostics (IVD) Quality Control Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Rising Prevalence of Chronic Diseases Across Saudi Arabia, Turkey, and Egypt

Chronic diseases and conditions are on the rise globally. An aging population and a sedentary lifestyle are contributing to a steady increase in long-term health problems. An increasing prevalence of chronic and infectious diseases has led to the launch of rapid diagnostic and testing tools by leading market players. Besides, the rising adoption of self-test and point-of-care devices is further accelerating the growth of in-vitro diagnostics devices across the globe

Thus, the increasing number of chronic disease are expected to accelerate the growth of the IVD quality control market significantly in the nearby future.

  • Rising Adoption of Quality Control Solutions in Laboratories and Hospitals

Laboratory testing of patient samples can be a complex procedure, depending on clinical analysis, microbiological study, or blood banking testing among other facets of the clinical laboratory. Quality control (QC) is one of the most important impacts on laboratory testing-it ensures both the precision and accuracy of patient sample results. The integrity of quality control samples is important to both management of overall quality as well as to meeting requirements of proficiency testing.

Thus, the rising adoption of quality control solutions in laboratories and hospitals is expected to drive the market growth.

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market

Opportunities

  • Rise in Strategic Acquisition and Partnership among Organizations

Recently, different organizations are stepping forward for partnership and collaboration to develop IVDs that are essential for detecting diseases. Not only can this, with the help of partnerships and agreements, both the companies develop a new suite of technologies and platforms that will help to detect diseases.

With the help of a long-term agreement, both companies can provide dimensional pricing IVDs in response to consumer demand in the market. Such partnership and mutual agreement not only benefit both the companies but are also creating a lot of opportunities for the market to grow.

  • Rising Research and Development Activities

Across the globe, the spending on research and development activities is escalating owing to public health expenditure with economic performance. Whereas, the healthcare industry ranks second among all industries when it comes to the amount it spends on research and development. Rising healthcare expenditure has further resulted in better provision of research and development opportunities. Consequently, it has enhanced the demand for IVD regulatory affairs outsourcing services across the region.

Restraints/Challenges

  • High Cost Related to Quality Control and Maintenance of IVD

In vitro diagnostics (IVD) are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person's overall health to help cure, treat, or prevent diseases.

IVD of analytes originating from body specimens, including blood and tissue biopsies, is used alone or in combination with clinical investigations and is perceived as an important tool for high-quality medical outcomes, hence maintaining of IVD and quality control of IVD devices costs high for carrying out accurate tests.

Hence, the rising cost of the maintenance of IVD has become a deciding factor for the companies in the servicing process, which is further restraining the growth of the market to an extent. 

  • Stringent Regulations Regarding IVD in Saudi Arabia, Turkey, and Egypt

The use of IVDs across the globe is rapidly increasing, with the growth of the aged population and several chronic diseases which are preventable by early diagnosis and timely treatments. At the same time, the players of the IVD devices in the market have to follow certain regulations to get approval from the upper authorities for the launching of the product in a region. These stringent guidelines need to be followed, and this is one of the most difficult tasks among all the steps. The pre-market approval of various medical devices varies from one country to another.

Therefore, the stringent rules & regulations for product approval act as restraints for the growth of the market.

Recent Development

  • In February 2023, Siemens Healthineers, a leading medical technology company, and Unilabs, a leading diagnostic services provider, announced a multi-year agreement valued at over €200 thousand. Unilabs has invested in Siemens Healthineers top-notch technology and will acquire more than 400 laboratory analyzers to further improve its laboratory infrastructure to offer an unparalleled service to its customers. This partnership has helped for latest diagnostic testing infrastructure to improve patients’ care.
  • In July 2021, Thermo Fisher Scientific, the world leader in serving science, announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS analyzers. This has helped the company to increase their global presence in the market.

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market Scope

Saudi Arabia, Turkey, and Egypt in vitro diagnostics (IVD) quality control market is segmented into four notable segments such as product and services, application, type, sector and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product and Services

  • Quality Control Products
  • Quality Control Services

On the basis of products and services, the Saudi Arabia, Turkey, and Egypt In vitro diagnostics (IVD) quality control market is segmented into quality control products and quality control services.

Applications

  • Clinical Chemistry
  • Immunochemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation/Hemostasis
  • Microbiology
  • Others

Based on applications, the Saudi Arabia, Turkey, and Egypt In vitro diagnostics (IVD) quality control market is segmented into clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation/hemostasis, microbiology, and others.

Sector

  • Clinical
  • Non-Clinical

Based on sector, the Saudi Arabia, Turkey, and Egypt In vitro diagnostics (IVD) quality control market is segmented into clinical and non-clinical.

End User

  • Clinical Laboratories
  • Academic And Research Institutes
  • Blood Banks
  • Biotechnology Industry
  • Pharmaceutical Industry
  • Others

Based on end users, the Saudi Arabia, Turkey, and Egypt In vitro diagnostics (IVD) quality control market is segmented into clinical laboratories, academic and research institutes, blood banks, biotechnology industry, pharmaceutical industry, and others.

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market

Competitive Landscape and In Vitro Diagnostics (IVD) Quality Control Market Share Analysis

The in vitro diagnostics (IVD) quality control market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the ataxia market.

Some of the major players operating in the In vitro diagnostics (IVD) quality control market are Bio-Rad Laboratories, Inc, Siemens Healthcare Private Limited, Sysmex Europe SE, Randox Laboratories Ltd., Sera Care, Thermo Fisher Scientific Inc., Beckman Coulter, Inc., Technopath Clinical Diagnostics, DiaSorin S.p.A., Agappe Diagnostics Ltd, and Spectrum Diagnostics. among others.


SKU-

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market is projected to grow at a CAGR of 4.8% during the forecast period by 2030.
The future market value of the Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market is expected to reach USD 1,260.66 thousand by 2030.
The major players in the Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market are Bio-Rad Laboratories, Inc, Siemens Healthcare Private Limited, Sysmex Europe SE, Randox Laboratories Ltd., Sera Care, Thermo Fisher Scientific Inc., etc.
The Saudi Arabia, Turkey, and Egypt in Vitro Diagnostics (IVD) Quality Control Market is segmented on the basis of product and services, application, type, sector and end user.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials